Cancer Letters
Volume 220, Issue 1 , Pages 21-28 , 18 March 2005

Selective induction of apoptosis in murine skin carcinoma cells (CH72) by an ethanol extract of Lentinula edodes

  • Yu-Huan Gu

      Affiliations

    • Bastyr University, 14500 Juanita Drive NE, WA 98028, USA
    • ,
  • Martha A. Belury

      Affiliations

    • Department of Human Nutrition, The Ohio State University, 1787 Neil Avenue, 325 Campbell Hall, Columbus, OH 43210, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-614-292-1680; fax: +1-614-292-8880.

Received 24 November 2003 ,Revised 15 June 2004 ,Accepted 16 June 2004.

References 

  1. Wasser SP, Weis AL. Medicinal properties of substances occurring in higher basidiomycete mushrooms: current perspectives (review). International Journal of Medicinal Mushrooms. 1999;1:31–62
  2. Ikekawa T, Uehara N, Maeda Y, Nankinishi M, Fukoka F. Antitumor activity of aqueous extracts of edible mushrooms. Cancer Research. 1969;29:734–735
  3. Reshetnikov SV, Wasser SP, Tan KK. Higher Basidiomycetes as a source of antitumor and immunostimulating polysaccharides (Review). International Journal of Medicinal Mushrooms. 2001;3:361–394
  4. Kidd PM. The use of mushroom glucans and proteoglycans in cancer treatment. Alternative Medicine Review. 2000;5(1):4–27
  5. White RWD, Hackman RM, Soares SE, Beckett LA, Sun B. Effects of mushroom mycelium extract on the treatment of prostate cancer. Urology. 2002;60:640–644
  6. Jong SC, Donovick R. Antitumor and antiviral substances from fungi. Advances in Applied Microbiology. 1989;34:183–261
  7. Conti CJ, Fries JW, Viaje A, Miller DR, Morris R, Slaga TJ. In vivo behavior of murine epidermal cell lines derived from initiated and noninitiated skin. Cancer Research. 1988;48:435–439
  8. Rundhaug JE, Park J, Pavone A, Opdenakker G, Fisher SM. Opposite effect of stable transfection of bioactive transforming growth factor-β1 (TGFβ1) versus exogenous TGF β1 treatment on expression of 92-kDa type IV collagenase in mouse skin squamous cell carcinoma CH72 cells. Molecular Carcinogenesis. 1997;19:122–136
  9. Coligan J. Morphological, biochemical, and flow cytometric assays of apoptosis. In Current Protocols in Immunology. New York: Wiley; 1995;
  10. Boik J. In:  Farnell S editors. Natural Compounds in Cancer Therapy. Washington, DC: Cataloging-in-Publication; 2001;
  11. Hobbs C. Medicinal mushrooms: an exploration of tradition, healing and culture. Santa Cruz, CA: Botanica Press; 1995;
  12. Borchers AT, Stern JS, Hackman RM. Mushrooms, tumors, and immunity. Proceedings of the Society for Experimental Biological Medicine. 1999;221:281–293
  13. Ross GD, Vetvicka V, Yan J, Xia Y, Vetvickova J. Therapeutic intervention with complement and beta-glucan in cancer. Immunophamacology. 1999;42:61–74
  14. Jong SC, Birmingham JM, Pai SH. Immunomodulatory substances of fungal origin. Journal of Immunology and Immunopharmacology. 1991;11:115–122
  15. Fujimiya Y, Suzuki Y, Oshiman K, Kobori H, Moriguchi K, Nakashima H, et al. Selective tumoricidal effect of soluble proteoglucan extracted from the basidiomycete, Agaricus blazei Murill, mediated via natural killer cell activation and apoptosis. Cancer Immunology and Immunotherapy. 1998;43(3):147–159
  16. Fullerton SA, Samadi AA, Tortorelis DG, Choudhury MS, Mallouh C, Tazaki H, et al. Induction of apoptosis in human prostatic cancer cells with beta-glucan (Maitake mushroom polysaccharide). Molecular Urology. 2000;4(1):7–13
  17. Finkelstein MP, Aynehchi S, Samadi AA, Drinis S, Choudhury MS, Tazaki H, et al. Chemosensitization of carmustine with maitake beta-glucan on androgen-independent prostate cancer cells: involvement of glyoxalase I. Journal of Alternative & Complementary Medicine. 2002;8(5):573–580
  18. Sherr CJ. Cancer cell cycles. Science. 1996;274(6):1672–1677
  19. Chihara G, Hamuro J, Maeda Y, Arai Y, Fukuoka F. Fractionation and purification of the polysaccharides with marked antitumor activity, especially Lentinan, from Letinus edodes (Berk.), Sing., an edible mushroom. Cancer Research. 1970;30:2776–2781
  20. Hobbs C. Medicinal value of Lentinus edodes (Berk.) Sing A literature review. International Journal of Medicinal Mushrooms. 2000;2:287–302
  21. Jones K. Shiitake, a major medicinal mushroom. Alternative & Complementary Therapies. 1998;1998:53–59
  22. Ng M-L, Yap A-T. Inhibition of human colon carcinoma development by Lentinan from Shiitake mushrooms (Lentinus edodes). Journal of Alternative & Complementary Medicine. 2002;8:581–589
  23. Chihara G. Immunophamacology of Lentinan, a polysaccharide isolated from Lentinula edodes: its applications as a host defence potentiator. International Journal of Oriental Medicine. 1992;17:57–77
  24. Maeda YY, Hamuro J, Chihara G. The mechanisms of action of antitumor polysaccharides: The effects of anti-lymphocyte serum on the antitumor activity of Lentinan. Internationsl Journal of Cancer. 1971;8:41–46
  25. Sugiyama K, Akachi T, Yamakawa A. Eritadenine-induced alteration of hepatic phospholipids metabolism in relation to its hypocholesterolemic action in rats. Journal of Nutritional Biochemistry. 1995;6:80–87
  26. Sia GM, Candlish JK. Effects of shiitake (Lentinus edodes) extract on human neutrophils and the U937 monocytic cell line. Phytotherapy Research. 1999;13(2):133–137
  27. Ghoneum M, Wimbley M, Salem F, Mcklain A, Attalan N, Gill G. Immunomodulatory and anticancer effects of active hemicellulose compound (AHCC). International Journal of Immunetherapy. 1995;11:23–28

PII: S0304-3835(04)00473-2

doi: 10.1016/j.canlet.2004.06.037

Cancer Letters
Volume 220, Issue 1 , Pages 21-28 , 18 March 2005

Article Tools

* Image Usage & Resolution